BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31621033)

  • 1. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal.
    Peltrini R; Sacco M; Luglio G; Bucci L
    Updates Surg; 2020 Mar; 72(1):29-37. PubMed ID: 31621033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
    Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 6. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes.
    Asoglu O; Tokmak H; Bakir B; Aliyev V; Saglam S; Iscan Y; Bademler S; Meric S
    J Robot Surg; 2020 Jun; 14(3):393-399. PubMed ID: 31313071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
    Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
    Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
    van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
    J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Rectal Cancer Without Radical Resection.
    Beets GL; Figueiredo NF; Beets-Tan RG
    Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
    Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
    Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.
    Allaix ME; Arezzo A; Morino M
    Surg Endosc; 2016 Nov; 30(11):4841-4852. PubMed ID: 26902614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in organ preserving strategies in rectal cancer patients.
    Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
    Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we
    Rombouts AJM; Al-Najami I; Abbott NL; Appelt A; Baatrup G; Bach S; Bhangu A; Garm Spindler KL; Gray R; Handley K; Kaur M; Kerkhof E; Kronborg CJ; Magill L; Marijnen CAM; Nagtegaal ID; Nyvang L; Peters FP; Pfeiffer P; Punt C; Quirke P; Sebag-Montefiore D; Teo M; West N; de Wilt JHW;
    BMJ Open; 2017 Dec; 7(12):e019474. PubMed ID: 29288190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of rectal cancer: the 2016 French guidelines.
    Lakkis Z; Manceau G; Bridoux V; Brouquet A; Kirzin S; Maggiori L; de Chaisemartin C; Lefevre JH; Panis Y;
    Colorectal Dis; 2017 Feb; 19(2):115-122. PubMed ID: 27801543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.
    Marks JH; Montenegro GA; Salem JF; Shields MV; Marks GJ
    Tech Coloproctol; 2016 Jul; 20(7):467-73. PubMed ID: 27178183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
    Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
    Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.